Intriguingly, the increased IFNγ expression in this scenario upon CCL2 blockade and decrease in MDSC iNOS expression did not result in reciprocal IFNγ upregulation, indicating that therapeutic strategies that inhibit MDSC iNOS-mediated suppression can effectively boost anti-tumour immunity without being self-limiting. The gene discussed is IFNG; the disease is neoplasm.